194 related articles for article (PubMed ID: 20841423)
1. CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia.
Uckun FM; Goodman P; Ma H; Dibirdik I; Qazi S
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16852-7. PubMed ID: 20841423
[TBL] [Abstract][Full Text] [Related]
2. CD22ΔE12 as a molecular target for corrective repair using RNA trans-splicing: anti-leukemic activity of a rationally designed RNA trans-splicing molecule.
Uckun FM; Qazi S; Ma H; Reaman GH; Mitchell LG
Integr Biol (Camb); 2015 Feb; 7(2):237-49. PubMed ID: 25567759
[TBL] [Abstract][Full Text] [Related]
3. Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL.
Uckun FM; Mitchell LG; Qazi S; Liu Y; Zheng N; Myers DE; Song Z; Ma H; Cheng J
EBioMedicine; 2015 Jul; 2(7):649-59. PubMed ID: 26288837
[TBL] [Abstract][Full Text] [Related]
4. Screening of Variations in CD22 Gene in Children with B-Precursor Acute Lymphoblastic Leukemia.
Aslar Oner D; Akin DF; Sipahi K; Mumcuoglu M; Ezer U; Kürekci AE; Akar N
Genet Test Mol Biomarkers; 2016 Sep; 20(9):552-5. PubMed ID: 27486888
[TBL] [Abstract][Full Text] [Related]
5. CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.
Ma H; Qazi S; Ozer Z; Gaynon P; Reaman GH; Uckun FM
Br J Haematol; 2012 Jan; 156(1):89-98. PubMed ID: 22017452
[TBL] [Abstract][Full Text] [Related]
6. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
7. CD22 Exon 12 Deletion as an Independent Predictor of Poor Treatment Outcomes in B-ALL.
Qazi S; Uckun FM
Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900389
[TBL] [Abstract][Full Text] [Related]
8. CD22ΔE12 as a molecular target for RNAi therapy.
Uckun FM; Ma H; Cheng J; Myers DE; Qazi S
Br J Haematol; 2015 May; 169(3):401-14. PubMed ID: 25659406
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice.
Mary C; Laporte C; Parzy D; Santiago ML; Stefani F; Lajaunias F; Parkhouse RM; O'Keefe TL; Neuberger MS; Izui S; Reininger L
J Immunol; 2000 Sep; 165(6):2987-96. PubMed ID: 10975807
[TBL] [Abstract][Full Text] [Related]
10. Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies.
Zheng S; Gillespie E; Naqvi AS; Hayer KE; Ang Z; Torres-Diz M; Quesnel-Vallières M; Hottman DA; Bagashev A; Chukinas J; Schmidt C; Asnani M; Shraim R; Taylor DM; Rheingold SR; O'Brien MM; Singh N; Lynch KW; Ruella M; Barash Y; Tasian SK; Thomas-Tikhonenko A
Blood Cancer Discov; 2022 Mar; 3(2):103-115. PubMed ID: 35015683
[TBL] [Abstract][Full Text] [Related]
11. Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.
Ryland GL; Barraclough A; Fong CY; Fleming S; Bajel A; Hofmann O; Westerman D; Grimmond S; Blombery P
Br J Haematol; 2020 Oct; 191(1):123-126. PubMed ID: 32648276
[No Abstract] [Full Text] [Related]
12. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
13. Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev AO; Mao C; Uckun FM
Leuk Lymphoma; 2003 Jun; 44(6):1011-8. PubMed ID: 12854903
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance.
Paul MR; Wong V; Aristizabal P; Kuo DJ
J Pediatr Hematol Oncol; 2019 Nov; 41(8):e546-e549. PubMed ID: 30807395
[TBL] [Abstract][Full Text] [Related]
15. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions.
D'Adamio L; Shipp MA; Masteller EL; Reinherz EL
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7103-7. PubMed ID: 2528730
[TBL] [Abstract][Full Text] [Related]
16. Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients.
Uckun FM; Ma H; Ishkhanian R; Arellano M; Shahidzadeh A; Termuhlen A; Gaynon PS; Qazi S
PLoS One; 2013; 8(11):e80732. PubMed ID: 24278314
[TBL] [Abstract][Full Text] [Related]
17. Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomas.
Uckun FM; Qazi S
Cancer Drug Resist; 2018; 1():30-47. PubMed ID: 31788667
[TBL] [Abstract][Full Text] [Related]
18. Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.
Bednar KJ; Shanina E; Ballet R; Connors EP; Duan S; Juan J; Arlian BM; Kulis MD; Butcher EC; Fung-Leung WP; Rao TS; Paulson JC; Macauley MS
J Immunol; 2017 Nov; 199(9):3116-3128. PubMed ID: 28972089
[TBL] [Abstract][Full Text] [Related]
19. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
[TBL] [Abstract][Full Text] [Related]
20. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
Carstens RP; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
